Triampur (DIURETICS)

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Triampur (DIURETICS)

Property Description
Active Ingredient Triamterene
Pharmacological Class Potassium-sparing diuretic
Form Tablet or Capsule (Oral)
Common Use Managing fluid volume (e.g., in edema or hypertension)
Origin Synthetic (Chemically manufactured)

What Type of Drug is Triampur (Triamterene)?

Triampur is a synthetic prescription medication classified as a diuretic, widely known as a water pill, whose active ingredient is Triamterene. It is a potassium-sparing diuretic, a class of medicine clinically recognized for its ability to help the kidneys excrete salt and water while protecting against the excessive loss of potassium. This unique feature is essential for maintaining the body's delicate balance of electrolytes during fluid removal. Triamterene, the active pharmaceutical ingredient (INN), is a small molecule compound taken by the oral route, most commonly in the form of a tablet or capsule. It can be formulated as a monotherapy (containing only Triamterene) or, more frequently, as a fixed-dose combination product alongside a thiazide diuretic, such as hydrochlorothiazide.


How Does Triamterene Affect Fluid Balance?

The primary general purpose of Triamterene is to regulate the volume of excess fluid in the body, contributing to the management of fluid retention (edema) and high blood pressure (hypertension). Its mechanism principle involves the sodium channel inhibition in the kidney, which prevents the reabsorption of sodium back into the bloodstream. This action promotes diuresis while actively maintaining potassium levels. This makes Triamterene particularly useful in typical scenarios where a diuretic is needed, but the patient is susceptible to hypokalemia (low potassium), offering a balanced approach to fluid management.

Regulatory References

  1. Triamterene: MedlinePlus Drug Information
  2. Triamterene - LiverTox - NIH

What side effects are possible with Triampur (DIURETICS)?

Possible Side Effects of Triampur

Triampur (a combination of triamterene and hydrochlorothiazide) is generally prescribed for managing hypertension and edema, but like all medications, it can cause side effects. These often relate to changes in fluid and electrolyte balance.


Common Side Effects

Commonly reported side effects are usually mild and may include frequent urination, dizziness, headache, gastrointestinal upset (nausea, vomiting, or diarrhea), and dry mouth.

System Common Side Effects (Examples)
Central Nervous System Dizziness, headache, fatigue
Gastrointestinal Nausea, vomiting, dry mouth, upset stomach
Metabolic Changes in potassium (hypokalemia or hyperkalemia), hyponatremia (low sodium), hyperuricemia (increased uric acid)

Serious Side Effects and Warnings

Serious side effects require immediate medical attention.

  • Electrolyte Imbalance: A primary concern is hyperkalemia (high potassium) due to the triamterene component. Symptoms include confusion, irregular heartbeat, muscle weakness, and numbness or tingling in the hands or feet.
  • Kidney Issues: Triampur may lead to kidney stone formation or worsening of existing kidney dysfunction. A sudden decrease in urine output or swelling of extremities should be reported.
  • Hypersensitivity and Vision Changes: Rare but serious reactions include severe allergic reactions (e.g., rash, swelling of the face, difficulty breathing) or sudden eye pain and blurred vision (acute angle-closure glaucoma).
  • Photosensitivity: The medication can increase skin sensitivity to sunlight, raising the risk of severe sunburn and potentially increasing the risk of non-melanoma skin cancer with long-term use. Protective clothing and sunscreen are essential.

Contraindications and Precautions

Triampur should not be used in patients with severe kidney disease (anuria) or existing hyperkalemia. Use with caution is necessary in patients with a history of gout, diabetes, or severe liver disease. Regular blood tests are necessary to monitor kidney function, potassium levels, and other electrolytes throughout treatment.

Overdose and Emergency Response

Overdose Scope

Documented overdose presentations: Nausea, vomiting, upset stomach, severe dizziness, weakness, tiredness, and muscular cramps. The physiological systems primarily affected are the Cardiovascular (Hypotension, Tachycardia, Arrhythmias), Metabolic/Electrolyte (Hyperkalemia, Metabolic Acidosis), and Central Nervous Systems (Seizures, Confusion, Collapse).

Population-specific overdose notes: The risk of severe Hyperkalemia—the primary life-threatening outcome—is increased in the elderly, in patients with renal impairment, or in individuals with diabetes mellitus. Official documentation also notes a risk of precipitating hepatic coma in patients with pre-existing severe hepatic dysfunction.

Emergency-response statements: Immediately call emergency services (911) if the victim has collapsed, had a seizure, has trouble breathing, or cannot be awakened. Contact Poison Control for guidance. Immediate medical help is required if the overdose leads to loss of consciousness or symptoms of life-threatening cardiac irregularities, as uncorrected Hyperkalemia may be fatal.

Resulting Overdose Structure

  • Overdose is documented to cause severe manifestations of volume depletion and electrolyte imbalance, with the critical danger being uncorrected Hyperkalemia, which may be fatal and is associated with cardiac irregularities.
  • Treatment is symptomatic and supportive, requiring the frequent monitoring of serum electrolytes and an Electrocardiogram (ECG) evaluation.
  • No specific antidote is known; management focuses on procedures like gastric decontamination and interventions such as dialysis or infusion of glucose and insulin to manage potassium levels.

Connection to the overall overdose profile: The official labeling defines the Triamterene overdose profile by emphasizing the potential for life-threatening Hyperkalemia and resulting cardiac complications. The regulatory guidance requires immediate contact with emergency medical services when severe symptoms or loss of consciousness occur. Overdose management is officially described as supportive, focusing on correcting fluid and electrolyte balance.

Therapeutic Uses of Triampur (DIURETICS)

Triampur is commonly used to help with conditions characterized by periods of heightened symptoms such as high blood pressure and fluid retention, and it is applied across domains where additional symptomatic support is needed. This medication is relevant for easing symptoms related to systemic imbalance that can occur in conditions involving episodic or fluctuating manifestations.

The combination of Triamterene and Hydrochlorothiazide (HCTZ) may be part of symptomatic management for hypertension (high blood pressure) or edema (swelling caused by excess fluid). It is often used during phases when symptoms become more noticeable, particularly when additional management of discomfort is appropriate.

The combination assists with maintaining functional stability by reducing fluid volume. The potassium-sparing component supports maintaining electrolyte balance during symptomatic periods, which may assist with preventing a temporary systemic imbalance. The therapy supports the patient during difficult episodes by easing distress. It is commonly used to help with symptoms linked to organ-specific functional stress like fluid overload.

Quick Fact: Supports management of symptoms related to physical discomfort (e.g., swelling) and symptoms that create noticeable physiological strain.

Regulatory References

  1. NIH DailyMed official prescribing information

Eligibility and Restrictions for Use

Who Can and Cannot Use Triampur (DIURETICS)?

Official regulatory labeling explicitly defines specific patient populations who must not use Triampur (Triamterene) and those who require restricted use. The medicine is contraindicated and must not be used by patients with hyperkalemia (high serum potassium levels) or those suffering from anuria (inability to pass urine).

Individuals with severe renal impairment or severe hepatic disease are also ineligible for this medication. Furthermore, use is prohibited for patients currently taking other potassium-sparing diuretics (such as spironolactone) or potassium supplements, or those with a known allergy to triamterene or sulfonamide-derived drugs.


Population Limitations

Specific limitations apply to certain populations. The safety and efficacy have not been established in the pediatric population (under 18 years old). Use is not recommended for women who are breastfeeding, and routine use in pregnancy is considered inappropriate. Older adult patients and individuals with diabetes or a history of kidney stones must use Triampur only with additional medical supervision and caution, as specified by official regulatory documents.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Triamterene establishes constraints primarily related to potassium balance and renal clearance.

Formal Contraindicated Combinations

Co-administration with other potassium-sparing diuretics (e.g., amiloride, spironolactone) is formally contraindicated. Similarly, the use of potassium supplements or potassium-containing salt substitutes is prohibited due to the significant and potentially fatal risk of hyperkalemia (abnormally high serum potassium levels).

Interacting Product Categories

Category Documented Interaction Outcome
ACE Inhibitors and ARBs Increased risk of hyperkalemia (additive effect).
NSAIDs (e.g., Indomethacin) Increased hyperkalemia risk and potential for renal impairment.
Lithium Preparations Diuretics can reduce Lithium's renal clearance, increasing exposure and risk of toxicity.
Cationic Drugs (e.g., Amantadine, Amiodarone) Altered drug exposure via competition for renal tubular clearance.
Alcohol Risk of enhanced hypotensive effect (additive blood pressure lowering).
High-Fat Meals Documented to increase the bioavailability of Triamterene (and its active metabolite) in some fixed-dose combination products.

Population-Specific Constraints

Regulatory documentation notes that the hyperkalemia risk is particularly heightened for patients with pre-existing renal function impairment or diabetes mellitus. Triamterene use is strictly constrained by a patient's baseline serum potassium level and renal function.

Mechanism of Action

How Triampur (Triamterene) Works

Triamterene's mechanism of action is confined to the distal nephron of the kidney, primarily acting on the principal cells of the collecting duct. Its function is defined by the specific, non-competitive blockade of the Epithelial Sodium Channel ( ENaC), which is located on the luminal membrane of these cells. By physically obstructing this channel, the drug immediately prevents the reabsorption of sodium ( Na^+) from the tubular fluid back into the bloodstream.

The resulting physiological cascade has two components. First, the retained Na^+ creates an osmotic gradient that causes water to remain in the urine, leading to diuresis (increased fluid excretion) and natriuresis (increased Na^+ excretion). Second, the inhibition of Na^+ reabsorption eliminates the negative electrical potential within the tubular lumen. This dissipation removes the necessary electrochemical driving force that facilitates the secretion and subsequent excretion of potassium ( K^+) and hydrogen ions ( H^+). This mechanism results in the conservation of K^+ and alters electrolyte balance by promoting the excretion of sodium and water while limiting K^+ output.

Dosage and Administration Information

Official Administration Instructions for Triampur

The following instructions pertain to the oral use of this fixed-combination diuretic agent.

Route and Timing

Instruction Category Guideline
Route of Administration Oral (by mouth)
Frequency Twice daily (in the morning and at noon)
Timing with Meals Always take after a meal
Preparation Swallow the tablets with liquid (e.g., one glass of water)

Dosing Guidelines (Adults and Adolescents > 50 kg)

The typical dosage for adults and adolescents weighing over 50 kg is taken twice daily.

  • For High Blood Pressure: Typically 2 tablets two times daily.
  • For Water Retention (Edema): Typically 2 to 4 tablets two times daily.
  • For Heart Failure (Adjunct Therapy): Typically 1 to 2 tablets two times daily.

Specific Patient Populations and Procedures

  • Children and Adolescents (< 50 kg): The medicine is generally not recommended for use in this weight group.
  • Impaired Organ Function: Patients with impaired liver or kidney function may require a reduction in the dose or an extension of the dosing interval, which must be determined in consultation with a physician.
  • Missed Dose: If a dose is missed, do not take double the amount at the next scheduled time; instead, continue the regular dosing schedule as prescribed.
  • Discontinuation: Treatment should be ended gradually by tapering the dose to avoid adverse effects from sudden cessation.

Recent Clinical Evidence

Research evidence / Overview of studies for Triampur (DIURETICS)


Evidence for Managing High Blood Pressure (Hypertension)

Research exploring the combination product containing Triamterene and a thiazide diuretic was evaluated in studies examining high blood pressure (hypertension), which primarily included Randomized Controlled Trials (RCTs) and systematic reviews. These efforts focused on adults with mild to moderate essential hypertension, monitoring changes in blood pressure measurements. Findings indicate that the combination product was associated with lower pressure measurements. A critical outcome studied was serum potassium; when Triamterene was added, studies reported a lower incidence of hypokalemia (abnormally low potassium) compared to when the thiazide was used alone.

What remains unclear is that long-term effects are not fully established based on contemporary, dedicated trials. The age of the primary data is a limiting factor, and there is limited information for long-term outcomes from studies focusing specifically on Triamterene used as a monotherapy for blood pressure control.


Evidence for Managing Fluid Retention (Edema)

Triamterene was evaluated in research examining fluid retention (edema), a condition often characterized by outcomes related to physical discomfort. This research included RCTs that examined hospitalized and non-hospitalized adults with edema linked to conditions such as congestive heart failure and hepatic cirrhosis. Researchers monitored changes in body weight and urine output to measure physiological changes related to fluid balance. The combination product was observed in trials where fluid loss was monitored.

Sample sizes were modest in some specialized studies. Because fluid retention can stem from various underlying medical issues, the evidence quality varies across studies due to the different patient groups included.


Evidence for Protecting Potassium Levels

The primary and most consistently evaluated effect of Triamterene was studied for its role in examining potassium levels when administered alongside other diuretics. This effect was observed in focused trial designs. These trials focused on serum potassium concentration and the percentage of study participants who developed hypokalemia. Findings describe consistent patterns showing that the addition of Triamterene was associated with the maintenance of higher serum potassium levels compared to when the thiazide was used alone. Researchers also observed and tracked the potential occurrence of hyperkalemia (abnormally high potassium levels), as studies monitor this outcome closely.


What is Still Uncertain About Triampur (DIURETICS)

There is a key gap in recent, robust research examining Triamterene as a single agent (monotherapy) for either hypertension or edema; the most consistent and definitive evidence relates to the fixed-dose combination product. Additionally, comparative evidence is lacking from recent, modern trials that would compare Triamterene-containing regimens against newer medications used for hypertension or fluid retention.

Key Studies & References

  1. Triamterene - StatPearls - NCBI Bookshelf

Frequently Asked Questions (FAQ)

Common questions about Triampur (DIURETICS) (FAQ)

Q: How quickly does Triampur start working after taking it?

Regulatory information indicates that the diuretic effect of this medication begins relatively quickly. The Triamterene component may start working within 2 to 4 hours after taking the tablet, while the Hydrochlorothiazide component typically begins its action within 2 hours.

Q: Does Triampur make you pee a lot, and how long does that effect last?

The drug is designed to increase fluid excretion, leading to more frequent urination. Official product information describes the diuretic action of the components persisting for different lengths of time, ranging from approximately 6 to 16 hours overall.

Q: Can Triampur affect my sleep if I take it too late in the day?

To help prevent excessive trips to the bathroom that could interrupt sleep, drug labels advise patients to take the medication during the day. Official administration instructions specify timing the tablets earlier in the day.

Q: Are there any specific foods or drinks to avoid while taking Triampur?

Yes, official information advises against using potassium-containing salt substitutes while taking this medication. Additionally, it notes that high-fat meals can increase the body's absorption of the Triamterene component.

Q: What should be known about taking Triampur if I have kidney issues?

Regulatory documents state that patients with impaired kidney function may need an adjustment to their prescribed dose or a change in how often they take the medicine. The medication is officially described as contraindicated for individuals who are unable to pass urine (anuria) or have severe kidney disease.

Q: Is Triampur considered safe for older adults or elderly patients?

Official documents note that older adults may be at a greater risk for certain side effects, particularly high potassium levels (hyperkalemia). Official guidance indicates that use in this population requires additional medical supervision and caution.

Q: What are the common signs of dehydration associated with taking Triampur?

While the medicine helps remove excess fluid, regulatory warnings about fluid and electrolyte imbalance note that signs of dehydration can occur. These signs may include increased thirst, a dry mouth, general weakness, muscle cramps, and feeling dizzy.

Q: Why do official documents mention monitoring electrolytes when using this drug?

The Triamterene component is a potassium-sparing diuretic, which means it limits potassium loss. Official warnings emphasize that this can sometimes lead to hyperkalemia, which is an abnormally high level of potassium in the blood. For this reason, official guidance requires frequent laboratory tests to monitor potassium and other electrolyte levels.

Q: Can people with diabetes still use Triampur safely?

Regulatory information indicates that close monitoring is required for patients with diabetes. This is because the drug may raise blood sugar levels and can increase the risk of high potassium.

Q: How is the long-term safety profile of Triampur generally characterized?

Official research summaries indicate that long-term effects for this drug combination are not fully established based on recent, dedicated clinical trials. The primary evidence supporting its use is based on older data, and continuous use requires periodic monitoring.

Q: What are the main goals of treatment when using Triampur for heart failure?

For the treatment of heart failure, official documents indicate this medication is used as an add-on therapy. Its primary goal is to manage and reduce fluid retention (edema) by helping the body remove excess water.

Q: What is the difference between Triampur and other common water pills?

Triampur is officially described as a fixed-dose combination product containing two types of medicine: a thiazide diuretic and the potassium-sparing diuretic Triamterene. This combination is intended to help the body eliminate salt and water while conserving potassium, which is a key difference from other single-agent water pills that may cause significant potassium loss.

Q: Can taking Triampur cause someone to feel dizzy or lightheaded?

Yes, regulatory documents list feeling dizzy and lightheaded as common side effects of this medication. This is often related to the intended changes in fluid and blood pressure levels.

Q: Does Triampur have an impact on blood sugar levels?

Official regulatory warnings state that this medication may raise blood sugar levels. Because of this potential effect, it can alter insulin requirements in patients who are being treated for diabetes.

Q: Is it common to feel unusually tired when starting Triampur?

Fatigue and weakness are listed among the reported side effects in official documents. These symptoms may also be related to changes in the body's fluid balance or electrolyte levels.

Q: Are there specific times of the day that Triampur is typically taken?

Official administration instructions specify that this medication is typically taken twice daily, in the morning and at noon. Official instructions indicate that the tablets are taken after a meal.

Q: What is the risk of having a serious allergic reaction to Triampur?

While the frequency is not specified in regulatory documents, serious allergic reactions are possible and are listed as situations requiring emergency medical review. Signs may include a severe rash, swelling of the face, or difficulty breathing.

Q: Can Triampur cause a dry mouth or increased thirst?

Dry mouth is listed as a common side effect of the medication. Additionally, increased thirst is noted in regulatory warnings as a potential sign of fluid or electrolyte imbalance that may occur during treatment.

Q: Are there reasons why Triampur might suddenly stop working effectively?

Official documents note that the drug’s effectiveness can potentially be reduced by several factors. This includes a diet that is too high in salt, or the concurrent use of certain other medicines, such as nonsteroidal anti-inflammatory drugs (NSAIDs).

Q: Is it safe to drive or operate machinery while taking Triampur?

Regulatory guidance states that activities requiring alertness, such as driving or operating machinery, should be avoided until one is certain how the medicine affects them. This caution is due to the potential risk of dizziness or blurred vision.

Q: What are the eligibility restrictions for using Triampur?

Official documents list pre-existing high potassium levels, the inability to pass urine, severe kidney or liver disease, and other conditions as eligibility restrictions. It is also restricted for concurrent use with other potassium-sparing diuretics or potassium supplements.

Q: How often are follow-up appointments generally needed when on Triampur?

Regulatory documents state that laboratory tests, including those for kidney function and serum potassium, should be performed periodically and at frequent intervals. These tests are noted as important for monitoring progress and checking for potential side effects.

Q: Are there any reported cognitive or mood changes linked to Triampur?

While specific mood disorders are not listed, regulatory warnings about fluid and electrolyte imbalance note that symptoms like confusion and drowsiness are potential warning signs that require attention.

Q: Does the medicine Triampur show up on standard drug screening tests?

Official documents indicate that Triamterene, one of the active ingredients, has a fluorescence profile similar to the drug quinidine. This similarity is noted to potentially interfere with specific laboratory tests used for measuring quinidine levels.

Q: Are there any official reports of Triampur affecting vision or hearing?

Regulatory documents list blurred vision as a potential adverse reaction. They also warn about a rare, serious side effect described as sudden eye pain and decreased vision, which may suggest acute angle-closure glaucoma.

Q: How long does the body take to fully remove Triampur after stopping use?

Official documents provide estimates of half-life, with one component estimated to take several days to be largely removed from the body. It is advised to discuss cessation with a healthcare professional.

Q: Is it common for people to switch from a different diuretic to Triampur?

Official documentation indicates that this combination drug is specifically intended for patients who have developed or are considered to be at risk for developing potassium loss (hypokalemia) when taking a thiazide diuretic alone. This suggests it is often used as a replacement or upgrade regimen.

How should Triampur (DIURETICS) be stored and disposed of?

Official Storage Requirements

Triampur (Triamterene/Hydrochlorothiazide) tablets must be stored according to regulatory requirements to maintain product stability and integrity.

Storage Requirement Official Condition
Temperature Store at Controlled Room Temperature (20 C to 25 C).
Environment Protect from light and moisture. Do not freeze or store in excessive heat.
Container Keep in the tightly closed original container.

The medication must be kept out of the reach of children.


️ Disposal Instructions

Expired or unused Triampur must be properly disposed of. Patients should consult a pharmacist or healthcare professional for specific disposal guidance, which often involves using a drug take-back program. The medicine should generally not be flushed down the toilet or poured into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Triampur (DIURETICS) found in:

A-Z Index: